Select a section from the left sidebar
Cabralealactone
- Family: Plantae - Capparaceae
- Kingdom: Plantae
-
Class: Terpenoid
- Subclass: Dammarane Triterpenoid
Canonical Smiles | O=C1CC[C@@](O1)(C)[C@H]1CC[C@@]2([C@@H]1CC[C@H]1[C@@]2(C)CC[C@@H]2[C@]1(C)CCC(=O)C2(C)C)C |
---|---|
InChI | InChI=1S/C27H42O3/c1-23(2)19-10-15-26(5)20(24(19,3)13-11-21(23)28)8-7-17-18(9-14-25(17,26)4)27(6)16-12-22(29)30-27/h17-20H,7-16H2,1-6H3/t17-,18+,19+,20-,24+,25-,26-,27+/m1/s1 |
InChIKey | NOLGXQBEFHYZHI-QPBHWVAKSA-N |
Formula | C27H42O3 |
HBA | 3 |
HBD | 0 |
MW | 414.63 |
Rotatable Bonds | 1 |
TPSA | 43.37 |
LogP | 6.34 |
Number Rings | 5 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Fraction CSP3 | 0.93 |
Exact Mass | 414.31 |
Number of Lipinski Rule Violations | 1 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Cleome africana | Capparaceae | Plantae | 860685 |
Showing of synonyms
Cabralealactone
19865-87-3
CHEBI:70268
(5S)-5-methyl-5-[(5R,8R,9R,10R,13R,14R,17S)-4,4,8,10,14-pentamethyl-3-oxo-1,2,5,6,7,9,11,12,13,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]oxolan-2-one
18-Norcholan-24-oic acid, 20-hydroxy-4,4,8,14-tetramethyl-3-oxo-, gamma-lactone, (5alpha)-
Cabralelactone
CHEMBL225315
DTXSID801316890
AKOS032962392
FS-9520
CS-0023628
Q27138607
(20S)-23,24-epoxy-25,26,27-trinordammarane-3,24-dione
(5alpha)-4,4,8,14-tetramethyl-20,24-epoxy-18-norcholane-3,24-dione
18-Nor-5-cholan-24-oic acid, 20-hydroxy-4,4,8,14-tetramethyl-3-oxo-, -lactone, (20S)-
18-Nor-5-cholanic acid, 20-hydroxy-4,4,8,14-tetramethyl-3-oxo-, -lactone
Pubchem:
44421647
Cas:
19865-87-3
Zinc:
ZINC000028639129
Chebi:
70268
Nmrshiftdb2:
60072285
Metabolights:
MTBLC70268
Chembl:
CHEMBL225315
CPRiL:
418589
SMILES: O=C1CCC(O1)C2CCC(C23)C4C(CC3)C5C(CC4)CC(=O)CC5
Level: 1
Mol. Weight: 414.63 g/mol
SMILES: C1CCC(C12)CCC3C2CCC4C3CCC(=O)C4
Level: 0
Mol. Weight: 414.63 g/mol
SMILES: O=C1CCCO1
Level: 0
Mol. Weight: 414.63 g/mol
Cytotoxic
Absorption
- Caco-2 (logPapp)
- -4.8
- Human Oral Bioavailability 20%
- Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- -4.78
- Human Oral Bioavailability 50%
- Bioavailable
- P-Glycoprotein Inhibitor
- Inhibitor
- P-Glycoprotein Substrate
- Non-Substrate
- Skin Permeability
- -1.99
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Penetrable
- Fraction Unbound (Human)
- 1.74
- Plasma Protein Binding
- 79.23
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Non-Inhibitor
- CYP 1A2 Inhibitor
- Non-Inhibitor
- CYP 1A2 Substrate
- Substrate
- CYP 2C19 Inhibitor
- Non-Inhibitor
- CYP 2C19 Substrate
- Non-Substrate
- CYP 2C9 Inhibitor
- Non-Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Substrate
- OATP1B1
- Non-Inhibitor
- OATP1B3
- Non-Inhibitor
Excretion
- Clearance
- 10.32
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Safe
- Bee
- Toxic
- Bioconcentration Factor
- -0.1
- Biodegradation
- Safe
- Carcinogenesis
- Safe
- Crustacean
- Toxic
- Liver Injury I (DILI)
- Toxic
- Eye Corrosion
- Safe
- Eye Irritation
- Safe
- Maximum Tolerated Dose
- 0.47
- Liver Injury II
- Toxic
- hERG Blockers
- Toxic
- Daphnia Maga
- 5.89
- Micronucleos
- Safe
- NR-AhR
- Safe
- NR-AR
- Toxic
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Toxic
- NR-PPAR-gamma
- Safe
- NR-TR
- Safe
- T. Pyriformis
- -32.25
- Rat (Acute)
- 2.05
- Rat (Chronic Oral)
- 1.36
- Fathead Minnow
- 3.92
- Respiratory Disease
- Safe
- Skin Sensitisation
- Toxic
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Safe
- SR-p53
- Safe
General Properties
- Boiling Point
- 478.97
- Hydration Free Energy
- -3.82
- Log(D) at pH=7.4
- 5.01
- Log(P)
- 4.69
- Log S
- -6.15
- Log(Vapor Pressure)
- -7.84
- Melting Point
- 216.56
- pKa Acid
- 10.9
- pKa Basic
- 6.74
Protein Name | UniProt ID | Entry Name | Species | #Pharmacophore Points | Probability (0.7 ≤ Tversky Score ≤ 1.0) |
---|---|---|---|---|---|
Aldo-keto reductase family 1 member D1 | P51857 | AK1D1_HUMAN | Homo sapiens | 3 | 0.8254 |
Aldo-keto reductase family 1 member D1 | P51857 | AK1D1_HUMAN | Homo sapiens | 3 | 0.8254 |
Aldo-keto reductase family 1 member C2 | P52895 | AK1C2_HUMAN | Homo sapiens | 3 | 0.8112 |
Aldo-keto reductase family 1 member C2 | P52895 | AK1C2_HUMAN | Homo sapiens | 3 | 0.8112 |
CmeR | Q7B8P6 | Q7B8P6_CAMJU | Campylobacter jejuni | 3 | 0.8081 |
CmeR | Q7B8P6 | Q7B8P6_CAMJU | Campylobacter jejuni | 3 | 0.8081 |
Aldo-keto reductase family 1 member C2 | P52895 | AK1C2_HUMAN | Homo sapiens | 3 | 0.7480 |
Aldo-keto reductase family 1 member C2 | P52895 | AK1C2_HUMAN | Homo sapiens | 3 | 0.7480 |
Aldo-keto reductase family 1 member C1 | Q04828 | AK1C1_HUMAN | Homo sapiens | 3 | 0.7352 |
Aldo-keto reductase family 1 member C1 | Q04828 | AK1C1_HUMAN | Homo sapiens | 3 | 0.7352 |
Soluble acetylcholine receptor | Q8WSF8 | Q8WSF8_APLCA | Aplysia californica | 3 | 0.7314 |
Soluble acetylcholine receptor | Q8WSF8 | Q8WSF8_APLCA | Aplysia californica | 3 | 0.7314 |
Mineralocorticoid receptor | P08235 | MCR_HUMAN | Homo sapiens | 4 | 0.7195 |
Mineralocorticoid receptor | P08235 | MCR_HUMAN | Homo sapiens | 4 | 0.7195 |